ASCLS eNewsBytes

• New Breath Test Could Quickly Diagnose Bacterial Infections March 31, 2026
  Research highlights a potential noninvasive method for diagnosing bacterial infections through breath-based tests. This approach is increasingly important due to rising antibiotic resistance.
• Dual Immune Response May Keep HIV in Check Without Medication March 31, 2026
  In a study, researchers observed patients who ceased their daily HIV medication following an experimental treatment, noting that in a small group, the virus has not recurred.
• FDA Approves Oral Icotrokinra for Moderate to Severe Plaque Psoriasis March 31, 2026
  The FDA has approved icotrokinra for treating moderate to severe plaque psoriasis in adults and pediatric patients aged 12 and older, weighing at least 40kg, who are candidates for systemic therapy or phototherapy.
• From Pathology Image to Biological Discovery March 31, 2026
  Microscopic images of human tissue are essential for biomedical research and clinical diagnostics, but analyzing these images systematically and linking them with other biological data poses significant challenges.
• FDA Approves Imcivree for Acquired Hypothalamic Obesity March 31, 2026
  The FDA has approved setmelanotide for long-term reduction of excess body weight in adults and children aged 4 and older with acquired hypothalamic obesity.